FineMark National Bank & Trust’s Puma Biotechnology PBYI Stock Holding History

FineMark National Bank & Trust’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7	Closed	-$1K	–	1445
2015 Q3	$1K	Buy	7 +1	+17%	+$95	﹤0.01%	1419
2015 Q2	$1K	Hold	6	–	–	﹤0.01%	1363
2015 Q1	$1K	Buy	6 +3	+100%	+$641	﹤0.01%	1345
2014 Q4	$1K	Hold	3	–	–	﹤0.01%	1356
2014 Q3	$1K	Sell	3 -7	-70%	-$1.44K	﹤0.01%	1331
2014 Q2	$1K	Hold	10	–	–	﹤0.01%	1350
2014 Q1	$1K	Sell	10 -4	-29%	-$470	﹤0.01%	1365
2013 Q4	$1K	Buy	+14	New	+$822	﹤0.01%	1427

Other funds holding PBYI

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return